Anti-Cytochrome P450 2A6 [RP1.2B4]
Invented by Ayham Alnabulsi from Vertebrate Antibodies Limited
Invented at Vertebrate Antibodies Limited
- Datasheet
- References (1)
- Inventor Info
Info
Catalogue Number | 152158 |
Applications | WB |
Antigen/Gene or Protein Targets | Cytochrome P450 2A6, CYP2A6 |
Reactivity | Human |
Relevance | Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Constitutes the major nicotine C-oxidase. Possesses low phenacetin O-deethylation activity. |
Host | Mouse |
Immunogen | Human cytochrome P450 CYP2A6 |
Positive Control | western blot: Recombinant P450 - 0.49 pmol per lane. |
Subclass | IgG1 kappa |
Myeloma Used | P3X63Ag8.653 |
Recommended Growing Conditions | Dulbecco’s media containing 20% Fetal Bovine serum (DH20) prepared as follows (for final volume of 300ml: 237ml DMEM plus 60 ml Fetal Bovine Serum plus 3ml L-Glutamine). |
Strain | Balb/c |
Research Area | Cancer, Cardiovascular, Cell Signaling & Signal Transduction, Metabolism |
References: 1 entry
Barnes, T. S. (1987). The generation and characterization of monoclonal antibodies to human cytochrome P450. Ph. D. Thesis. University of Aberdeen.
Add a reference
References: 1 entry
Barnes, T. S. (1987). The generation and characterization of monoclonal antibodies to human cytochrome P450. Ph. D. Thesis. University of Aberdeen.
Add a reference